BROOKE HARBOR HEALTH SYSTEM INTRANET ALL TRAINING SYSTEMS OPERATIONAL
Brooke Harbor Health System

Brooke Harbor Health System

PMHNP Clinical Learning Environment

TRAINING ENVIRONMENTFictional educational health system · No real patient data

Condition Guide

Condition GuideAssessment, differential, treatment, and monitoring guidance.

Neurodevelopmental Disorders

Attention, social communication, learning, and adaptive functioning are understood across development. Establish onset, collateral history, and impairment across settings before naming a disorder, and look for the co-occurring conditions that are the rule rather than the exception.

Clinical application

Using this resource

Apply these prompts within the simulated clinical context. They support—but do not replace—clinical judgment, supervision, consultation, current guidance, local policy, law, or emergency procedures.

Use this when

  • Attention, activity, social communication, learning, language, motor, or adaptive concerns need characterization, including adults seeking first evaluation.

Clarify first

  • Onset in the developmental period, symptoms across settings, collateral sources (caregivers, teachers, school records, partners), prior evaluations, and sensory, sleep, medical, substance, and trauma contributors.

Act now

  • Name the best-supported diagnosis or the need for formal testing, address safety and function, and match supports to the person's own goals.

Document and communicate

  • Record sources of history, settings affected, standardized measures, functional impact, accommodations in place, and the referral or follow-up plan.

Diagnostic Features

Development is the frame

DSM-5-TR diagnosis requires onset in the developmental period, impairment, and exclusions, not symptom counts alone.

Two or more settings

Attention-deficit/hyperactivity disorder

Six or more inattentive and/or hyperactive-impulsive symptoms (five or more at age 17 and older) for at least 6 months; several symptoms present before age 12 and in two or more settings; symptoms interfere with functioning and are not better explained by another disorder. Specify combined, predominantly inattentive, or predominantly hyperactive-impulsive presentation.

Social communication + restricted patterns

Autism spectrum disorder

Persistent deficits in social-emotional reciprocity, nonverbal communication, and relationships, plus at least two restricted or repetitive patterns (stereotyped movement or speech, insistence on sameness, intense interests, sensory hyper- or hyporeactivity). Symptoms begin early but may not be apparent until demands exceed capacity. Specify support level, intellectual and language impairment, and associated conditions.

Intellectual + adaptive deficits

Intellectual developmental disorder

Deficits in intellectual functioning confirmed by clinical assessment and individualized standardized testing, with deficits in conceptual, social, and practical adaptive functioning, beginning in the developmental period. Severity is defined by adaptive functioning, not IQ score alone.

At least 6 months despite intervention

Specific learning disorder

Persistent difficulty with reading, written expression, or mathematics despite targeted intervention, with skills substantially below age expectations on standardized achievement measures, beginning during school-age years and not better explained by intellectual disability, sensory deficits, or inadequate instruction.

Language, speech, fluency, pragmatics

Communication disorders

Language disorder, speech sound disorder, childhood-onset fluency disorder, and social (pragmatic) communication disorder. Social (pragmatic) communication disorder is distinguished from autism by the absence of restricted, repetitive patterns.

Coordination and movement

Neurodevelopmental motor disorders

Developmental coordination disorder and stereotypic movement disorder. Tic disorders are covered in the Obsessive-Compulsive, Tourette's, and Tic Disorders guide.

Open the OCD & Tic Disorders guide →

Rating Scales & Screening

Measure symptom burden with the correct instrument

Screening supports case finding and follow-up; diagnosis requires a comprehensive evaluation.

Assessment & Differential

Gather the developmental story

Developmental history and collateral

Milestones, school records and report cards, prior evaluations, teacher and caregiver input; for adults, childhood history from a parent, sibling, or old records when possible.

Medical and sensory contributors

Hearing and vision, sleep disorders including sleep apnea, seizures, thyroid disease, lead exposure, medications, substance use, and genetic or syndromic causes; refer for genetic evaluation when intellectual disability or autism is diagnosed.

Key distinctions

Anxiety, depression, trauma, bipolar disorder, sleep deprivation, substance use, learning or language disorders, intellectual disability, and an unstable or unsafe environment can resemble or accompany ADHD. ADHD and autism can be diagnosed together. Oppositional defiant disorder, conduct disorder, and disruptive mood dysregulation disorder often co-occur with ADHD; see the Child & Adolescent Psychiatry specialty area.

Child & Adolescent Psychiatry specialty area →

Culture, language, and masking

Assess in the person's preferred language with a qualified interpreter; learning two languages is not a language disorder. Girls, women, and adults may camouflage autistic traits or present with predominantly inattentive ADHD, delaying diagnosis.

Treatment

Match support to development and goals

ADHD in children and adolescents

Ages 4–5: parent training in behavior management first, with methylphenidate considered if improvement is insufficient and impairment persists. Ages 6–11: FDA-approved medication with parent training and/or behavioral classroom interventions. Adolescents: medication with the adolescent's assent, plus behavioral and skills-based interventions. Coordinate school supports.

ADHD in adults

Stimulants (methylphenidate and amphetamine formulations) are first-line pharmacotherapy; nonstimulants are options when stimulants are unsuitable or not tolerated. CBT for adult ADHD and organizational skills coaching help with function. Before prescribing, review cardiac history and family history of sudden death, blood pressure and heart rate, substance use, and diversion risk, and check the prescription monitoring program. Stimulant labeling carries a boxed warning for misuse, abuse, addiction, and diversion.

Autism

No medication treats the core features. Offer developmental and behavioral supports, speech-language and occupational therapy, and caregiver-mediated interventions, and treat co-occurring conditions. Risperidone and aripiprazole are FDA-approved for irritability associated with autism in youth; monitor metabolic and movement effects.

Intellectual and learning disorders

Educational supports, accommodations, and adaptive-skills training. Psychiatric care focuses on co-occurring conditions. A change in behavior may signal pain, illness, or a medication effect, so avoid diagnostic overshadowing and minimize polypharmacy.

Monitoring & Coordination

Follow function, adverse effects, and the care environment

Medication monitoring

Appetite, weight, and growth in youth; blood pressure and heart rate; sleep, mood, tics, and misuse or diversion. With antipsychotics, monitor metabolic labs and involuntary movements (AIMS).

School and work

Individualized Education Programs (IDEA), Section 504 plans, college disability services, and workplace accommodations under the ADA.

Transitions

Pediatric-to-adult care transfer, supported decision-making or guardianship when needed, vocational and day supports, and state developmental disability services.

Family and caregivers

Caregiver stress, respite, sibling needs, and safety planning such as wandering and water safety for some autistic children.

Clinical Sources

Use current guidance and patient-specific evidence

These sources support clinical reasoning but do not replace a complete assessment, current prescribing information, local policy, consultation, or individualized shared decision-making.

Last updated October 25, 2026